These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 2306818

  • 1. Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
    Strony J, Phillips M, Brands D, Moake J, Adelman B.
    Circulation; 1990 Mar; 81(3):1106-14. PubMed ID: 2306818
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.
    Matsuno H, Kozawa O, Niwa M, Uematsu T.
    Circulation; 1997 Aug 19; 96(4):1299-304. PubMed ID: 9286962
    [Abstract] [Full Text] [Related]

  • 3. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain.
    McGhie AI, McNatt J, Ezov N, Cui K, Mower LK, Hagay Y, Buja LM, Garfinkel LI, Gorecki M, Willerson JT.
    Circulation; 1994 Dec 19; 90(6):2976-81. PubMed ID: 7994845
    [Abstract] [Full Text] [Related]

  • 4. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
    Weinstein M, Vosburgh E, Phillips M, Turner N, Chute-Rose L, Moake J.
    Blood; 1991 Nov 01; 78(9):2291-8. PubMed ID: 1932745
    [Abstract] [Full Text] [Related]

  • 5. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
    Roux SP, Sakariassen KS, Turitto VT, Baumgartner HR.
    Arterioscler Thromb; 1991 Nov 01; 11(5):1182-91. PubMed ID: 1911705
    [Abstract] [Full Text] [Related]

  • 6. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K, Cissé-Thiam M, Drouet L.
    Thromb Haemost; 1996 Jan 01; 75(1):203-10. PubMed ID: 8713802
    [Abstract] [Full Text] [Related]

  • 7. Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo.
    Kawasaki T, Kaku S, Kohinata T, Sakai Y, Taniuchi Y, Kawamura K, Yano S, Takenaka T, Fujimura Y.
    Am J Hematol; 1994 Sep 01; 47(1):6-15. PubMed ID: 8042618
    [Abstract] [Full Text] [Related]

  • 8. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep 01; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 9. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG, Sill JC, Berger I, Folts JD, Milde JH.
    Anesthesiology; 1993 Apr 01; 78(4):733-43. PubMed ID: 8466073
    [Abstract] [Full Text] [Related]

  • 10. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM.
    Circ Res; 1992 Jan 01; 70(1):39-48. PubMed ID: 1727687
    [Abstract] [Full Text] [Related]

  • 11. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
    Wadanoli M, Sako D, Shaw GD, Schaub RG, Wang Q, Tchernychev B, Xu J, Porter TJ, Huang Q.
    Thromb Haemost; 2007 Aug 01; 98(2):397-405. PubMed ID: 17721623
    [Abstract] [Full Text] [Related]

  • 12. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
    Rovin JD, Stamler JS, Loscalzo J, Folts JD.
    J Cardiovasc Pharmacol; 1993 Oct 01; 22(4):626-31. PubMed ID: 7505366
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.
    Boncler MA, Golanski J, Paczuski R, Watala C.
    J Mol Med (Berl); 2002 Dec 01; 80(12):796-801. PubMed ID: 12483465
    [Abstract] [Full Text] [Related]

  • 14. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S, Jiang M, Yan B, Shen F, He Y, Wan A, Xia L, Ruan C, Zhao Y.
    J Hematol Oncol; 2017 May 19; 10(1):111. PubMed ID: 28526067
    [Abstract] [Full Text] [Related]

  • 15. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP, Fressinaud E, Christophe O, Rouault C, Obert B, Takahashi Y, Meyer D.
    Thromb Haemost; 1992 Dec 07; 68(6):707-13. PubMed ID: 1287886
    [Abstract] [Full Text] [Related]

  • 16. Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis.
    Strony J, Song A, Rusterholtz L, Adelman B.
    Arterioscler Thromb Vasc Biol; 1995 Mar 07; 15(3):359-66. PubMed ID: 7749846
    [Abstract] [Full Text] [Related]

  • 17. [High shear stress induced platelet aggregation (h-SIPA) and effects of antiplatelet therapy].
    Isaka N, Tanigawa T, Nishikawa M, Nakano T.
    Nihon Rinsho; 1998 Oct 07; 56(10):2624-9. PubMed ID: 9796329
    [Abstract] [Full Text] [Related]

  • 18. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.
    Wagner CT, Kroll MH, Chow TW, Hellums JD, Schafer AI.
    Biorheology; 1996 Oct 07; 33(3):209-29. PubMed ID: 8935180
    [Abstract] [Full Text] [Related]

  • 19. Effects of trimetazidine on in vivo coronary arterial platelet thrombosis.
    Belcher PR, Drake-Holland AJ, Hynd JW, Noble MI.
    Cardiovasc Drugs Ther; 1993 Feb 07; 7(1):149-57. PubMed ID: 8485070
    [Abstract] [Full Text] [Related]

  • 20. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery.
    Matsuno H, Kozawa O, Niwa M, Tanabe K, Ichimaru K, Takiguchi Y, Yokota M, Hayashi H, Uematsu T.
    Thromb Haemost; 1998 Apr 07; 79(4):865-71. PubMed ID: 9569206
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.